{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:48:31Z","timestamp":1790743711611,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.medmal.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T10:39:53Z","timestamp":1573468793000},"page":"243-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Bleibtreu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bertine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Houhou-Fidouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Visseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2019.10.004_bib0380","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0385","unstructured":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). WHO; 2018. http:\/\/www.who.int\/emergencies\/mers-cov\/en\/.(accessed March 5, 2018)."},{"key":"10.1016\/j.medmal.2019.10.004_bib0390","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0140-6736(16)30623-7","article-title":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study","volume":"388","author":"Cho","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2019.10.004_bib0395","unstructured":"World Health Organization. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). World Health Organization; 2003. https:\/\/apps.who.int\/iris\/handle\/10665\/70863."},{"key":"10.1016\/j.medmal.2019.10.004_bib0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol 2017;"},{"key":"10.1016\/j.medmal.2019.10.004_bib0405","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00473-12","article-title":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans","volume":"3","author":"van Boheemen","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.medmal.2019.10.004_bib0410","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.2807\/ese.17.40.20290-en","article-title":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012","volume":"17","author":"Bermingham","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.medmal.2019.10.004_bib0415","unstructured":"WHO | Background and summary of novel coronavirus infection\u2013as of 21 December 2012. WHO; 2012. http:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/update_20121221\/en\/(accessed March 21, 2018)."},{"key":"10.1016\/j.medmal.2019.10.004_bib0420","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/JVI.02182-06","article-title":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features","volume":"81","author":"Woo","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.medmal.2019.10.004_bib0425","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(15)70090-3","article-title":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological stud","volume":"15","author":"M\u00fcller","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0430","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3201\/eid2006.140402","article-title":"Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013","volume":"20","author":"Memish","year":"2014","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0435","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3201\/eid2012.141026","article-title":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983\u20131997","volume":"20","author":"M\u00fcller","year":"2014","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0440","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3201\/eid2008.140596","article-title":"Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992\u20132013","volume":"20","author":"Corman","year":"2014","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0445","first-page":"22","article-title":"Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015","author":"Miguel","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.medmal.2019.10.004_bib0450","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.aac8608","article-title":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia","volume":"351","author":"Sabir","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.medmal.2019.10.004_bib0455","first-page":"3","article-title":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans","author":"van Boheemen","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.medmal.2019.10.004_bib0460","first-page":"8","article-title":"MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis","author":"Menachery","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.medmal.2019.10.004_bib0465","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1128\/JVI.00676-14","article-title":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4","volume":"88","author":"van Doremalen","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.medmal.2019.10.004_bib0470","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1073\/pnas.1407087111","article-title":"Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein","volume":"111","author":"Millet","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.medmal.2019.10.004_bib0475","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology","volume":"174","author":"Neuman","year":"2011","journal-title":"J Struct Biol"},{"key":"10.1016\/j.medmal.2019.10.004_bib0480","unstructured":"WHO | Middle East respiratory syndrome coronavirus (MERS-CoV)\u2013update. WHO; 2014. http:\/\/www.who.int\/csr\/don\/2014_05_15_mers\/en\/(accessed April 9, 2018)."},{"key":"10.1016\/j.medmal.2019.10.004_bib0485","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12916-015-0450-0","article-title":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study","volume":"13","author":"Chowell","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0490","unstructured":"New case of MERS-CoV identified in the United Kingdom. European Centre for Disease Prevention and Control 2018. http:\/\/ecdc.europa.eu\/en\/news-events\/new-case-mers-cov-identified-united-kingdom (accessed October 22, 2018)."},{"key":"10.1016\/j.medmal.2019.10.004_bib0495","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.tmaid.2014.10.006","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers","volume":"12","author":"Pavli","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0500","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiu292","article-title":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome","volume":"210","author":"Memish","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0505","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3201\/eid2111.150764","article-title":"Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014","volume":"21","author":"Feikin","year":"2015","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0510","unstructured":"WHO | Laboratory testing for Middle East Respiratory Syndrome Coronavirus. WHO; 2018. http:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/mers-laboratory-testing\/en\/(accessed April 9, 2018)."},{"key":"10.1016\/j.medmal.2019.10.004_bib0515","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.4131","article-title":"A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation","volume":"22","author":"Modjarrad","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0520","first-page":"629","article-title":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study","volume":"15","author":"M\u00fcller","year":"2015","journal-title":"Lancet Infect Dis 2015;"},{"key":"10.1016\/j.medmal.2019.10.004_bib0525","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.2807\/1560-7917.ES2013.18.14.20441","article-title":"Specific serology for emerging human coronaviruses by protein microarray","volume":"18","author":"Reusken","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.medmal.2019.10.004_bib0530","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jmv.24948","article-title":"Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection","volume":"90","author":"Trivedi","year":"2018","journal-title":"J Med Virol"},{"key":"10.1016\/j.medmal.2019.10.004_bib0535","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0140-6736(13)60982-4","article-title":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission","volume":"381","author":"Guery","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2019.10.004_bib0540","doi-asserted-by":"crossref","first-page":"e011865","DOI":"10.1136\/bmjopen-2016-011865","article-title":"Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015","volume":"7","author":"Alhamlan","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.medmal.2019.10.004_bib0545","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3947\/ic.2016.48.2.118","article-title":"Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea","volume":"48","author":"Choi","year":"2016","journal-title":"Infect Chemother"},{"key":"10.1016\/j.medmal.2019.10.004_bib0550","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1408636","article-title":"2014 MERS-CoV outbreak in Jeddah--a link to health care facilities","volume":"372","author":"Oboho","year":"2015","journal-title":"NEJM"},{"key":"10.1016\/j.medmal.2019.10.004_bib0555","doi-asserted-by":"crossref","first-page":"e2015033","DOI":"10.4178\/epih\/e2015033","article-title":"2015 MERS outbreak in Korea: hospital-to-hospital transmission","volume":"37","author":"Ki","year":"2015","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.medmal.2019.10.004_bib0560","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tmaid.2016.09.008","article-title":"Predictors of MERS-CoV infection: A large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia","volume":"14","author":"Mohd","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0565","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12879-017-2712-2","article-title":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients","volume":"17","author":"Ahmed","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0570","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMc1308698","article-title":"Middle East respiratory syndrome coronavirus infections in health care workers","volume":"369","author":"Memish","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0575","first-page":"1","article-title":"Estimating survival rates in MERS-CoV patients 14 and 45 days after experiencing symptoms and determining the differences in survival rates by demographic data, disease characteristics and regions: a worldwide study","volume":"2017","author":"Ahmed","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.medmal.2019.10.004_bib0580","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0585","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jegh.2016.05.002","article-title":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data","volume":"7","author":"Sherbini","year":"2017","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.medmal.2019.10.004_bib0590","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1306742","article-title":"Hospital outbreak of middle east respiratory syndrome coronavirus","volume":"369","author":"Assiri","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0595","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2019.10.004_bib0600","doi-asserted-by":"crossref","first-page":"e0165978","DOI":"10.1371\/journal.pone.0165978","article-title":"A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes","volume":"11","author":"Garbati","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.medmal.2019.10.004_bib0605","unstructured":"eCDC, Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV), 22nd update. European Centre for Disease Prevention and Control 2018. http:\/\/ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessment-severe-respiratory-disease-associated-middle-east-11 (accessed September 16, 2018)."},{"key":"10.1016\/j.medmal.2019.10.004_bib0610","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12879-018-3223-5","article-title":"Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016","volume":"18","author":"Bleibtreu","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12879-016-2137-3","article-title":"Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study","volume":"17","author":"Aleanizy","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0620","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0625","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3109\/0886022X.2015.1128772","article-title":"Middle East respiratory syndrome coronavirus infection: a short note on cases with renal failure problem","volume":"38","author":"Joob","year":"2016","journal-title":"Ren Fail"},{"key":"10.1016\/j.medmal.2019.10.004_bib0630","article-title":"State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans","volume":"5","author":"Who Mers-Cov Research Group","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.medmal.2019.10.004_bib0635","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cid\/ciu226","article-title":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients","volume":"59","author":"Al-Tawfiq","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0640","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","article-title":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia","volume":"29","author":"Saad","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0645","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.diagmicrobio.2017.07.006","article-title":"Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity","volume":"89","author":"Ko","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0650","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2017.02.001","article-title":"The impact of co-infection of influenza A virus on the severity of Middle East Respiratory Syndrome Coronavirus","volume":"74","author":"Alfaraj","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2019.10.004_bib0655","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000002621","article-title":"Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study","author":"Arabi","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0660","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2017.02.008","article-title":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea","volume":"58","author":"Nam","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0665","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/jac\/dkv085","article-title":"IFN-(2a or IFN-(1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study","volume":"70","author":"Shalhoub","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2019.10.004_bib0670","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3201\/eid2210.160218","article-title":"Viral RNA in blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection","volume":"22","author":"Kim","year":"2016","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0675","doi-asserted-by":"crossref","first-page":"25359","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"Min","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.medmal.2019.10.004_bib0680","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jinf.2016.08.005","article-title":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients","volume":"73","author":"Ko","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2019.10.004_bib0685","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2017.11.013","article-title":"Prevention and treatment of respiratory viral infections: presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference","volume":"149","author":"McKimm-Breschkin","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.medmal.2019.10.004_bib0690","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3201\/eid2209.151164","article-title":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia","volume":"22","author":"Arabi","year":"2016","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0695","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jiph.2017.08.009","article-title":"Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review","volume":"11","author":"Mustafa","year":"2018","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.medmal.2019.10.004_bib0700","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30002-1","article-title":"Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study","author":"Beigel","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0705","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1093\/jac\/dkw338","article-title":"A review of treatment modalities for Middle East Respiratory Syndrome","volume":"71","author":"Mo","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2019.10.004_bib0710","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000002621","article-title":"Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome","author":"Arabi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2019.10.004_bib0715","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijantimicag.2014.07.026","article-title":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen","volume":"44","author":"Spanakis","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2019.10.004_bib0720","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"Rossignol","year":"2016","journal-title":"J Infect Pub Health"},{"key":"10.1016\/j.medmal.2019.10.004_bib0725","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment With Lopinavir\/Ritonavir or Interferon-(1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0730","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12879-016-1492-4","article-title":"Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia","volume":"16","author":"Al Ghamdi","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2019.10.004_bib0735","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virusres.2016.11.011","article-title":"Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model","volume":"228","author":"de Wilde","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.medmal.2019.10.004_bib0740","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.12.010","article-title":"Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses","volume":"150","author":"M\u00fcller","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.medmal.2019.10.004_bib0745","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13613-017-0350-x","article-title":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus","volume":"8","author":"Alshahrani","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.medmal.2019.10.004_bib0750","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","article-title":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","volume":"35","author":"Alharbi","year":"2017","journal-title":"Vaccine"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X19310546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X19310546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:18:01Z","timestamp":1759972681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X19310546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0399077X19310546"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2019.10.004","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}